UNSPSC 51393703: Oxitropium bromide
Commodity
Code facts
- Part of
-
-
51000000
-
51390000
- 51393700
-
51390000
-
51000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 51393703
| NIGP code |
|---|
| 26912 Autonomic Drugs |
Definition
This classification denotes a bronchodilator and antimuscarinic agent with the molecular formula C19H26NO4.Br, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier SF4NW7NH7C, chemically known as 3-oxa-9-azoniatricyclo(3.3.1.0(sup 2,4))nonane, 9-ethyl-7-(3-hydroxy-1-oxo-2-phenylpropoxy)-9-methyl-, bromide, (7(s)-(1-alpha,2-beta,4-beta,5-alpha,7-beta))- but more generally known as oxitropium bromide, which bears US NIH Compound Identifier 34875.
Read the full definition
European Medicines Agency schedules Oxitropium bromide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09543MIG. The term OXITROPIUM BROMIDE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 31, No10, 1977, List 17). World Health Organization schedules oxitropium bromide in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations, for tariff and trade purposes, schedule oxitropium bromide under HS 29399900 and SITC 54149.
As of Q4 2014, OXITROPIUM BROMIDE remains US FDA's Preferred Term for this commodity. Oxitropium bromide bears US NLM identifiers UMLS ID C0134499 and NCI Concept Code C74157. SMILES: CC[N+]1([C@@H]2C[C@H](C[C@H]1[C@H]3[C@@H]2O3)OC(=O)[C@H](CO)C4CCCCC4)C.[BR-].
About UNSPSC 51393703
UNSPSC 51393703 Oxitropium bromide is a Commodity code that in recent state and local solicitations does not align with its pharmaceutical product scope. The two opportunities posted under this code in 2026 — a Seminole County, Florida naloxone and drug deactivation systems procurement and a Texas Health and Human Services Commission request for information on direct-to-manufacturer pharmacy programs — involve naloxone, drug deactivation products, and pharmacy benefit management rather than oxitropium bromide, a bronchodilator medication. The mismatch suggests either misclassification at the issuing body level or a data error in code assignment. State and local health departments and human services agencies appear as issuing bodies, but the code shows minimal recent activity aligned with its stated pharmaceutical scope.
Geographic activity centers on Texas and Florida based on the two posted opportunities. Seminole County released IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida; the bid response deadline was July 26, 2023. The Texas Health and Human Services Commission issued RFI HHS0017013 on April 3, 2026, to gather vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, designed as exploratory market intelligence rather than a binding solicitation. Both opportunities target product delivery and pharmacy program administration, but neither directly involves oxitropium bromide procurement.
Quick answers
What is UNSPSC 51393703?
UNSPSC 51393703 is Oxitropium bromide, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.
Which NIGP codes match UNSPSC 51393703?
UNSPSC 51393703 maps to 1 NIGP code, 26912 Autonomic Drugs.
On GovTribe
See everything under UNSPSC 51393703
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code